{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zukauskaite K"],"funding":["Lietuvos Mokslo Taryba","Research Council of Lithuania (LMTLT)"],"pagination":["4074"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11640656"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(23)"],"pubmed_abstract":["<h4>Background/objectives</h4>Neoadjuvant chemotherapy (NAC) followed by radical gastrectomy is the current standard approach for locally advanced gastric cancer (GC) in the West. Both NAC and gastrectomy can significantly influence the gut microbiome, potentially leading to clinically significant changes. However, no longitudinal studies to date support this hypothesis. This study investigates gut microbiome changes throughout GC treatment, including NAC and gastrectomy.<h4>Methods</h4>This longitudinal observational study included GC patients undergoing NAC followed by gastrectomy. Fecal microbiome composition, intestinal inflammation (fecal calprotectin), and gut permeability (LBP, sCD14) markers were investigated at baseline, after NAC, and after gastrectomy.<h4>Results</h4>A total of "],"journal":["Cancers"],"pubmed_title":["Gut Microbiome Changes After Neoadjuvant Chemotherapy and Surgery in Patients with Gastric Cancer."],"pmcid":["PMC11640656"],"funding_grant_id":["S-MIP-22-30"],"pubmed_authors":["Stadlbauer V","Mlynska A","Bausys A","Bausys B","Bausys R","Zukauskaite K","Jarmalaite S","Horvath A","Sabaliauskaite R","Sestokaite A"],"additional_accession":[]},"is_claimable":false,"name":"Gut Microbiome Changes After Neoadjuvant Chemotherapy and Surgery in Patients with Gastric Cancer.","description":"<h4>Background/objectives</h4>Neoadjuvant chemotherapy (NAC) followed by radical gastrectomy is the current standard approach for locally advanced gastric cancer (GC) in the West. Both NAC and gastrectomy can significantly influence the gut microbiome, potentially leading to clinically significant changes. However, no longitudinal studies to date support this hypothesis. This study investigates gut microbiome changes throughout GC treatment, including NAC and gastrectomy.<h4>Methods</h4>This longitudinal observational study included GC patients undergoing NAC followed by gastrectomy. Fecal microbiome composition, intestinal inflammation (fecal calprotectin), and gut permeability (LBP, sCD14) markers were investigated at baseline, after NAC, and after gastrectomy.<h4>Results</h4>A total of ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2026-04-23T03:25:10.635Z","creation":"2025-04-03T23:26:17.519Z"},"accession":"S-EPMC11640656","cross_references":{"pubmed":["39682264"],"doi":["10.3390/cancers16234074"]}}